|
Entorhinal Metabolism as a Predictor of MCI or AD |
||||||||||||||||||||||||||||||||
| From: DeLeon et al. PNAS 2001; 98: 10966 | ||||||||||||||||||||||||||||||||
|
PET superimposed to MRI Entorhinal ROI drawn on MRI |
Baseline PET in 12 subjects with MCI who in a follow up of 3 years developed progressive cognitive impairment (declining), compared to 13 subjects of similar age who did not |
|||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||
| Illustration of the location of the entorhinal region from Killiany R et al. Neurology 2002;58:1188 | The entorhinal cortex was the only region explored that at baseline had lower metabolism in the subjects who declined. This finding agrees with the finding that about 30% of entorhinal neurons are lost in people with MCI (Gomez-Isla T et al J Neurosc 1996) | |||||||||||||||||||||||||||||||